The bar chart compares the proportion of drug company’s total income, by region, from 2002 to 2006. Looking from an overall perspective, it is readily apparent that the drug sales in America and Europe was downward trend. Meanwhile, Asia has the contrast, and it has also become the largest drug sales market
Regarding America, in the first year, America sales were at 41% and there was a continuous decline until 2004 and until 2005 a pharmaceutical company’s sales in the America had an increase, and until 2005 2006, Sales reached 30%. Along with that, Europe also fluctuated in the 4 years from 2002 to 2006, the number continuously increasing in the first 3 years from 34% to 38%. However, in the last two years, Europe’s revenue decreased by 30%.
Turning to details of Asia, in 2002, the sales volume of an Asian pharmaceutical company was only 25%, which was also the lowest compared to the US and Europe. However, in the following years from 2003 to 2006, sales increased sharply by 40% and was the region with the highest sales in the last 2 years.